Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

DRY NEEDLING VS. CUPPING THERAPY IN MPS

30 juni 2026 bijgewerkt door: Fatma Nur BULDUK, Turkish League Against Rheumatism

COMPARISON OF THE EFFECTIVENESS OF DRY NEEDLING AND CUPPING THERAPY IN PATIENTS WITH MYOFASCIAL PAIN SYNDROME: A RANDOMIZED TRIAL

This study aimed to compare the effectiveness of dry needling and cupping therapy in patients diagnosed with myofascial pain syndrome involving the trapezius, supraspinatus, infraspinatus, and levator scapulae muscles. Treatment efficacy was evaluated using the visual analog scale (VAS), the number of trigger points, the Likert satisfaction scale, and the multidimensional quality of life scale.

Studie Overzicht

Toestand

Voltooid

Conditie

Interventie / Behandeling

Gedetailleerde beschrijving

This study evaluated the effectiveness of dry needling (DN) and cupping therapy in 92 patients with chronic myofascial pain syndrome. Participants were randomly divided into two groups: one receiving a 10-session cupping regimen and the other undergoing a three-session dry needling protocol, with both groups performing home-based exercises.

Results showed that both treatments significantly reduced pain and improved patient outcomes over three months. When compared directly, cupping therapy was more effective at reducing trigger points and improving overall quality of life. Conversely, dry needling resulted in higher levels of patient satisfaction. In conclusion, both methods are valuable tools for managing myofascial pain, and the choice of treatment may depend on whether the clinical priority is physical symptom relief or patient preference. Further research is recommended to better define the specific long-term applications of these therapies.

Studietype

Ingrijpend

Inschrijving (Werkelijk)

92

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studie Locaties

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

  • Volwassen

Accepteert gezonde vrijwilligers

Nee

Beschrijving

Inclusion Criteria:

  • Back pain lasting more than three months
  • At least one palpable myofascial TN in the trapezius, supraspinatus, infraspinatus, and/or levator scapulae muscles
  • Written informed consent

Exclusion Criteria:

  • Prior dry needling treatment
  • Prior cupping therapy
  • Severe cognitive dysfunction
  • Spinal fracture
  • Infection
  • Malignancy
  • Ankylosing spondylitis
  • Central nervous system injury
  • Psychiatric disorder
  • Diseases causing tissue degeneration
  • Conditions associated with spasticity or cerebrovascular disease
  • Cervical radiculopathy due to structural abnormalities
  • Muscle or tendon injuries of the shoulder or neck
  • Fibromyalgia or other conditions presenting with symptoms similar to myofascial pain syndrome
  • Use of anticoagulant or antiplatelet therapy
  • Thrombocytopenia or hemorrhagic disorders
  • A history of surgery or blood donation within the previous three months
  • Pregnancy
  • Breastfeeding
  • Presence of renal, hepatic, or severe cardiovascular disease

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Behandeling
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Geen (open label)

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Actieve vergelijker: Cupping therapy arm
Dry cupping was conducted 3 times per week for 9 sessions, followed by one session of wet cupping at the tenth session.
Procedure: Cupping therapy
In the tenth session, wet cupping was performed directly over the patients' TNs. In addition to the TNs, wet cupping was also applied at the Dazhui DU-14 point in all patients. Before initiating the procedure, the treatment area was disinfected with alcohol. Sterile single-use cups numbered 5 and 6 were applied to the treatment area. After 3 to 5 minutes, the cups were removed one at a time. After the area was cleaned, a No. 15 scalpel blade was used to make shallow vertical cuts at the cupping site. Afterward, the cups were returned to the same places. The procedure was performed three times without making any new cuts. The blood was drained, and the cups were put back on. The entire procedure lasted approximately 20 min. The cups were removed at the end of the procedure, and the area that had been treated was cleaned and covered properly.
Actieve vergelijker: Dry needling arm
Participants in this arm received three sessions of dry needling, administered once per week.
Procedure: Dry needling
Needling was performed while the TNs in the levator scapulae, supraspinatus, and upper part of the trapezius muscles were sitting. Patients were placed in the prone position for the middle and lower parts of the trapezius and infraspinatus muscles. To increase the accuracy of localization and minimize the risk of injury to nearby structures, needling was performed under ultrasound guidance. We used the Esaote MyLab 60 ultrasound machine that we have in our clinic for this. Standard single-use sterile acupuncture needles (0.25 mm × 25 mm) were used.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Visual analog scale
Tijdsspanne: From enrollment to the end of the first month
The VAS score was used to measure pain intensity in each patient. Patients were told to rate their pain on a 10-cm horizontal line for the VAS test. A score of 0 indicated no pain, a score of 5 indicated moderate pain, and a score of 10 indicated the worst pain.
From enrollment to the end of the first month
Trigger points count
Tijdsspanne: From enrollment to the end of the first month
Trigger points were identified in the trapezius, levator scapulae, supraspinatus, and infraspinatus muscles by the presence of a hypersensitive spot within a palpable taut band, accompanied by a visible or palpable LTR and/or reproduction of referred pain upon palpation of the sensitive point.
From enrollment to the end of the first month
Multidimensional quality of life score
Tijdsspanne: From enrollment to the end of the first month
The multidimensional quality of life scale includes a total of 35 items and assesses nine subdomains, each with four items. The overall score is obtained by summing the responses to all the items. Each item is given a score from 1 to 7, with a total score of 35 to 245. Higher scores indicate better functional status.
From enrollment to the end of the first month
Likert satisfaction scale
Tijdsspanne: From enrollment to the end of the first month
Patient satisfaction was assessed using a Likert scale, where participants were asked to rate their experience by selecting one of the following options: none, mild, moderately good, good, or very good.
From enrollment to the end of the first month

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Visual analog scale
Tijdsspanne: From enrollment to the end of the third month
The VAS score was used to measure pain intensity in each patient. Patients were told to rate their pain on a 10-cm horizontal line for the VAS test. A score of 0 indicated no pain, a score of 5 indicated moderate pain, and a score of 10 indicated the worst pain.
From enrollment to the end of the third month
Trigger points count
Tijdsspanne: From enrollment to the end of the third month
Trigger points were identified in the trapezius, levator scapulae, supraspinatus, and infraspinatus muscles by the presence of a hypersensitive spot within a palpable taut band, accompanied by a visible or palpable LTR and/or reproduction of referred pain upon palpation of the sensitive point.
From enrollment to the end of the third month
Multidimensional quality of life score
Tijdsspanne: From enrollment to the end of the third month
The multidimensional quality of life scale includes a total of 35 items and assesses nine subdomains, each with four items. The overall score is obtained by summing the responses to all the items. Each item is given a score from 1 to 7, with a total score of 35 to 245. Higher scores indicate better functional status.
From enrollment to the end of the third month
Likert satisfaction scale
Tijdsspanne: From enrollment to the end of the third month
Patient satisfaction was assessed using a Likert scale, where participants were asked to rate their experience by selecting one of the following options: none, mild, moderately good, good, or very good.
From enrollment to the end of the third month

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Sponsor

Turkish League Against Rheumatism

Medewerkers

Atatürk University Scientific Research Projects Coordination Unit

Onderzoekers

  • Studie directeur: Fatih Baygutalp, Medical doctor, Department of Physical Medicine and Rehabilitation, Ataturk University Faculty of Medicine

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

15 maart 2022

Primaire voltooiing (Werkelijk)

30 juni 2024

Studie voltooiing (Werkelijk)

29 augustus 2025

Studieregistratiedata

Eerst ingediend

30 juni 2026

Eerst ingediend dat voldeed aan de QC-criteria

30 juni 2026

Eerst geplaatst (Werkelijk)

7 juli 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

7 juli 2026

Laatste update ingediend die voldeed aan QC-criteria

30 juni 2026

Laatst geverifieerd

1 juni 2026

Meer informatie

Termen gerelateerd aan deze studie

Trefwoorden

Aanvullende relevante MeSH-voorwaarden

Andere studie-ID-nummers

  • B.30.2.ATA.0.01.00/286

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

JA

Beschrijving IPD-plan

All the patients' demographic characteristics, including age, sex, educational level, occupation, height and weight

IPD-tijdsbestek voor delen

Beginning 1 year after publication with no end date

IPD-toegangscriteria voor delen

Access to individual participant data (IPD) and supporting documentation is provided to the principal investigators and the designated research team. Additionally, access may be granted to journal editors and peer reviewers upon request for the purposes of data verification and manuscript evaluation. All shared information consists exclusively of de-identified, anonymized raw data to ensure participant privacy. Access is managed on a request-only basis, ensuring that data is shared securely and in accordance with ethical standards and institutional guidelines.

IPD delen Ondersteunend informatietype

  • LEERPROTOCOOL
  • ICF

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Klinische onderzoeken op Myofascial Pain Syndrome (MPS)

Klinische onderzoeken op Cupping therapy

Zoek naar vergelijkbare onderzoeken

Sponsors en medewerkers

Medische omstandigheden

Geneesmiddelinterventies

CROs by country

CROs in Ireland

Voorwaarden

Zeldzame ziekten

Geneesmiddelinterventies

Voedingssupplementen

Sponsor / medewerkers

Locaties

3
Abonneren